Alessio Filippone
Overview
Explore the profile of Alessio Filippone including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
100
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Filippone A, Rossi C, Rossi M, Di Micco A, Maggiore C, Forcina L, et al.
J Clin Med
. 2023 May;
12(9).
PMID: 37176599
The microbiota is now recognized as one of the major players in human health and diseases, including cancer. Regarding breast cancer (BC), a clear link between microbiota and oncogenesis still...
2.
Magno S, Rossi M, Filippone A, Rossi C, Guarino D, Maggiore C, et al.
Integr Cancer Ther
. 2022 Dec;
21:15347354221140327.
PMID: 36461673
Background: Physical activity (PA) can play a role in lowering the risk of breast cancer (BC), but also in reducing perioperative complications and treatments related side effects, improving the quality...
3.
Magno S, Filippone A, Accetta C, Rossi C, Rossi M, Maggiore C, et al.
Br J Surg
. 2022 Aug;
109(10):1013-1014.
PMID: 35909302
No abstract available.
4.
Rossi C, Maggiore C, Rossi M, Filippone A, Guarino D, Di Micco A, et al.
Integr Cancer Ther
. 2021 Oct;
20:15347354211040826.
PMID: 34670415
Background: Breast cancer (BC) survivors have physical and psychological needs that require convincing responses by health care providers. The quality of life issue and clinical unmet needs are among the...
5.
Bruno E, Oliverio A, Angelo Paradiso , Daniele A, Tommasi S, Terribile D, et al.
Clin Breast Cancer
. 2020 Dec;
21(3):e168-e176.
PMID: 33357965
Background: Women with deleterious mutations in BRCA1/2 have a high lifetime penetrance of developing breast cancer and/or ovarian cancer. Genetic and/or environmental factors may influence BRCA penetrance, and identifying modifiable...
6.
Bruno E, Oliverio A, Paradiso A, Daniele A, Tommasi S, Tufaro A, et al.
Cancers (Basel)
. 2020 Dec;
12(12).
PMID: 33322597
Women carriers of / mutations face a high lifetime risk (penetrance) of developing breast and/or ovarian cancer. Insulin-like growth factor I (IGF-I), body weight and markers of insulin resistance affect...
7.
Costantini L, Magno S, Albanese D, Donati C, Molinari R, Filippone A, et al.
Sci Rep
. 2018 Nov;
8(1):16893.
PMID: 30442969
Breast microbiota compositions are not well understood, and a few recent reports have begun to explore the correlation between breast tissue dysbiosis and cancer. Given that various methods for breast...